Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Net income | $388M | $625M | $466M | $793M | $595M | $627M |
| EPS (diluted) | $1.00 | $1.59 | $1.18 | $2.03 | $1.53 | $1.24 |
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$1.56B | -$1.23B | $217M | $1.14B | $160M | $1.74B |
| Share buybacks | $150M | $2.60M | $26.0M | $34.1M | $0.00 | $148M |
| Dividends paid | $453M | $461M | $488M | $613M | $656M | $753M |
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $358M | $447M | $445M | $660M | $514M | $569M |
| Total assets | — | $13.3B | $13.6B | $13.5B | $13.9B | $17.2B |
| Total liabilities | — | $7.36B | $7.70B | $7.49B | $7.91B | $9.79B |
| Long-term debt | — | $7.08B | $7.28B | $7.08B | $7.46B | $9.30B |
| Shareholders' equity | $5.75B | $5.94B | $5.88B | $6.02B | $5.95B | $7.40B |
| Retained earnings | — | -$56.4M | -$92.2M | $93.5M | $29.4M | -$120M |
| Shares (wtd avg diluted) | 389M | 392M | 394M | 390M | 390M | 506M |
Every figure is extracted from Blue Owl Capital Corp’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.